Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119875) titled 'Exploration of the Value of Tumor Hyperthermia in First-Line Treatment of Gastroesophageal Junction Cancer' on March 4.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Changzhi People's Hospital

Condition: Gastroesophageal junction cancer

Intervention: Hyperthermia Combined Group:None

Recruitment Status: Not Recruiting

Phase: Retrospective study

Date of First Enrollment: 2025-10-01

Target Sample Size: Hyperthermia Combined Group:100;First-line treatment group:100;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=263958 ...